Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Registry Study to Evaluate Extended NeuroStar® TMS Therapy for Adults With Major Depressive Disorder (MDD)

NCT05541302 is registered in ClinicalTrials.gov with Neuronetics as lead sponsor.

NCT NCT05541302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05541302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Registry Study to Evaluate Extended NeuroStar® TMS Therapy for Adults With Major Depressive Disorder (MDD)
Lead sponsor
Neuronetics
Phase
Observational
Overall status
Completed
Start date
November 1, 2008
Completion date
August 31, 2022
Enrollment
6,456 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)